MYRIAD GENETICS, INC. Sector valuations Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.39 USD | -1.04% |
|
-16.45% | -9.63% |
| Jan. 15 | Myriad Genetics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:45 PM | |
| Jan. 15 | Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance | MT |
Main competitors
| P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -11.14x | 1.555 | 0.17x | 1.26x | 29.02x | 53.89x | -.--% | 1.13B | ||
| 27.9x | 3.180 | 0.88x | 3.28x | 14.2x | 20.95x | +0.83% | 13.43B | ||
| 24.3x | 5.382 | 1.24x | 9.85x | 19.93x | 21.01x | +1.97% | 6.56B | ||
| 15.7x | - | 0.62x | 3.96x | 8.85x | 9.37x | - | 6.36B | ||
| 30.52x | 3.264 | 1.87x | 5.09x | 15.51x | 20.77x | +1.06% | 5.59B | ||
| -10.81x | -42.416300 | 0.52x | 6.75x | -20.72x | -12.25x | -.--% | 4.53B | ||
| 17.27x | 2.482 | 1.63x | - | - | - | +2.96% | 3.13B | ||
| 53.06x | 2.159 | -0.47x | 8.04x | 23.61x | 36.93x | +0.55% | 2.52B | ||
| -10.59x | 2.509 | 0.31x | 2.36x | -9.78x | -7.7x | -.--% | 1.83B | ||
| 41.35x | - | -1.74x | - | - | - | - | 1.55B | ||
| 16.3x | 1.873 | 0.7x | - | - | - | - | 1.44B | ||
| 24.73x | - | 0.85x | - | - | - | - | 1.23B | ||
| 63.19x | - | 1.82x | - | - | - | - | 1.22B | ||
| 27.09x | 4.365 | 1.12x | 6.11x | 20.24x | 22.37x | +0.80% | 1.16B | ||
| 17.79x | 1.142 | 0.46x | - | - | - | +2.78% | 1.04B | ||
| 12.28x | 1.767 | 0.64x | - | - | - | - | 1.03B | ||
| 14.9x | 2.927 | 0.63x | - | - | - | +2.36% | 830M | ||
| Average | 20.82x | -0.75 | 0.66x | 5.19x | 11.21x | 18.37x | +1.21% | 3.21B | |
| Weighted average by Cap. | 21.65x | -1.43 | 0.84x | 5.24x | 10.87x | 16.36x | +1.11% |
- Stock Market
- Equities
- MYGN Stock
- Sector Myriad Genetics, Inc.
- Sector valuations